Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening

Francys C. Verdial, Ruth Etzioni, Catherine Duggan, Benjamin O. Anderson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

BACKGROUND: Breast cancer incidence and mortality are influenced by early-detection methods, including mammographic screening. Demographic changes in US statistics serve as a model for changes that can be anticipated in countries where mammographic screening has not been implemented. METHODS: SEER statistics (1973-2013) for breast cancer mortality, incidence, stage at diagnosis, and age at diagnosis were examined. Temporal associations between screening changes and breast cancer demographics in the US were documented. FINDINGS: Before 1982 (pre-screening), breast cancer incidence in the US remained stable, with similar incidence of localized and regional cancers, and with in-situ disease comprising <2% of diagnosed disease.1 During the transitional phase of mammographic screening, breast cancer incidence increased. In 1991, breast cancer age-adjusted mortality rates began decreasing and have continued to decrease. In the post-screening phase, stage distribution stabilized, but now with localized and in-situ disease representing the majority of diagnosed cases. The median age at diagnosis has increased to 61 years. DISCUSSION: Mammographic screening increases breast cancer incidence, shifts the stage distribution toward earlier stage disease, and in high-income countries, is associated with improved survival. Whether similar improvement in breast cancer survival can be achieved in the absence of mammographic screening has yet to be conclusively demonstrated.

Original languageEnglish (US)
Pages (from-to)517-522
Number of pages6
JournalJournal of surgical oncology
Volume115
Issue number5
DOIs
StatePublished - Apr 1 2017
Externally publishedYes

Fingerprint

Demography
Breast Neoplasms
Incidence
Population
Mortality
Neoplasms

Keywords

  • breast cancer
  • mammography
  • screening

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening. / Verdial, Francys C.; Etzioni, Ruth; Duggan, Catherine; Anderson, Benjamin O.

In: Journal of surgical oncology, Vol. 115, No. 5, 01.04.2017, p. 517-522.

Research output: Contribution to journalArticle

Verdial, Francys C. ; Etzioni, Ruth ; Duggan, Catherine ; Anderson, Benjamin O. / Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening. In: Journal of surgical oncology. 2017 ; Vol. 115, No. 5. pp. 517-522.
@article{b4326218a54b4dec96e7fb75bda2dcf2,
title = "Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening",
abstract = "BACKGROUND: Breast cancer incidence and mortality are influenced by early-detection methods, including mammographic screening. Demographic changes in US statistics serve as a model for changes that can be anticipated in countries where mammographic screening has not been implemented. METHODS: SEER statistics (1973-2013) for breast cancer mortality, incidence, stage at diagnosis, and age at diagnosis were examined. Temporal associations between screening changes and breast cancer demographics in the US were documented. FINDINGS: Before 1982 (pre-screening), breast cancer incidence in the US remained stable, with similar incidence of localized and regional cancers, and with in-situ disease comprising <2{\%} of diagnosed disease.1 During the transitional phase of mammographic screening, breast cancer incidence increased. In 1991, breast cancer age-adjusted mortality rates began decreasing and have continued to decrease. In the post-screening phase, stage distribution stabilized, but now with localized and in-situ disease representing the majority of diagnosed cases. The median age at diagnosis has increased to 61 years. DISCUSSION: Mammographic screening increases breast cancer incidence, shifts the stage distribution toward earlier stage disease, and in high-income countries, is associated with improved survival. Whether similar improvement in breast cancer survival can be achieved in the absence of mammographic screening has yet to be conclusively demonstrated.",
keywords = "breast cancer, mammography, screening",
author = "Verdial, {Francys C.} and Ruth Etzioni and Catherine Duggan and Anderson, {Benjamin O.}",
year = "2017",
month = "4",
day = "1",
doi = "10.1002/jso.24579",
language = "English (US)",
volume = "115",
pages = "517--522",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening

AU - Verdial, Francys C.

AU - Etzioni, Ruth

AU - Duggan, Catherine

AU - Anderson, Benjamin O.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - BACKGROUND: Breast cancer incidence and mortality are influenced by early-detection methods, including mammographic screening. Demographic changes in US statistics serve as a model for changes that can be anticipated in countries where mammographic screening has not been implemented. METHODS: SEER statistics (1973-2013) for breast cancer mortality, incidence, stage at diagnosis, and age at diagnosis were examined. Temporal associations between screening changes and breast cancer demographics in the US were documented. FINDINGS: Before 1982 (pre-screening), breast cancer incidence in the US remained stable, with similar incidence of localized and regional cancers, and with in-situ disease comprising <2% of diagnosed disease.1 During the transitional phase of mammographic screening, breast cancer incidence increased. In 1991, breast cancer age-adjusted mortality rates began decreasing and have continued to decrease. In the post-screening phase, stage distribution stabilized, but now with localized and in-situ disease representing the majority of diagnosed cases. The median age at diagnosis has increased to 61 years. DISCUSSION: Mammographic screening increases breast cancer incidence, shifts the stage distribution toward earlier stage disease, and in high-income countries, is associated with improved survival. Whether similar improvement in breast cancer survival can be achieved in the absence of mammographic screening has yet to be conclusively demonstrated.

AB - BACKGROUND: Breast cancer incidence and mortality are influenced by early-detection methods, including mammographic screening. Demographic changes in US statistics serve as a model for changes that can be anticipated in countries where mammographic screening has not been implemented. METHODS: SEER statistics (1973-2013) for breast cancer mortality, incidence, stage at diagnosis, and age at diagnosis were examined. Temporal associations between screening changes and breast cancer demographics in the US were documented. FINDINGS: Before 1982 (pre-screening), breast cancer incidence in the US remained stable, with similar incidence of localized and regional cancers, and with in-situ disease comprising <2% of diagnosed disease.1 During the transitional phase of mammographic screening, breast cancer incidence increased. In 1991, breast cancer age-adjusted mortality rates began decreasing and have continued to decrease. In the post-screening phase, stage distribution stabilized, but now with localized and in-situ disease representing the majority of diagnosed cases. The median age at diagnosis has increased to 61 years. DISCUSSION: Mammographic screening increases breast cancer incidence, shifts the stage distribution toward earlier stage disease, and in high-income countries, is associated with improved survival. Whether similar improvement in breast cancer survival can be achieved in the absence of mammographic screening has yet to be conclusively demonstrated.

KW - breast cancer

KW - mammography

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=85013119729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013119729&partnerID=8YFLogxK

U2 - 10.1002/jso.24579

DO - 10.1002/jso.24579

M3 - Article

C2 - 28194807

AN - SCOPUS:85013119729

VL - 115

SP - 517

EP - 522

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 5

ER -